Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Team Develops Method to Monitor Tumors Without Radiation
Error: Contact form not found.
by JNS.org
A view of Hadassah Medical Center in Jerusalem’s Ein Kerem neighborhood. Photo: Almog via Wikimedia Commons.
JNS.org – Doctors at Jerusalem’s Hadassah Medical Center have developed a new method to monitor tumors without injecting patients with radioactive substances or exposing them to ionizing radiation.
The method, detailed in a study published Thursday in the Nature Communications journal, was developed by the director of the Center for Hyperpolarized MRI Molecular Imaging, Rachel Katz-Brull, and her team at Hebrew University of Jerusalem.
Katz-Brull showed that by using magnetic resonance imaging, the nucleus of a phosphorus atom can alert doctors to suspicious acidity levels in the body, thereby revealing the possible existence of a tumor. The researchers used a special technique that allowed them to more easily identify the nucleus, enabling it to appear to “shine” 10,000 times brighter than normal.
“This diagnostic tool relates to the metabolic activity of the cells in a tumor or other tissue that may be suspicious,” Katz-Brull said. “It may provide a better way to determine whether tumors are malignant or benign, and help test the efficacy of treatment.”
The groundbreaking method makes it possible to avoid a biopsy or other invasive procedures to measure a tissue’s acidity levels, and also to determine whether a tumor is malignant or benign without having the patients undergo unnecessary radiation or be exposed to radioactive materials.
